Stephen Chang

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

David B. Miklos, Corey Cutler, Mukta Arora et al. · Blood · 2017 · 499 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

Steven Coutré, John C. Byrd, Peter Hillmen et al. · Blood Advances · 2019 · 131 citations · Full text

Medicine, Oncology, Pharmacology +13

Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study

Edmund K. Waller, David B. Miklos, Corey Cutler et al. · Biology of Blood and Marrow Transplantation · 2019 · 112 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis

Jennifer R. Brown, Javid J. Moslehi, Michael S. Ewer et al. · British Journal of Haematology · 2018 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma

Susan O’Brien, Peter Hillmen, Steven Coutré et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 81 citations · Full text

Medicine, Hematology, Pharmacology +17